Press Releases

  • Highest bridge to human heart transplant rate of any heart device, 79%
  • Over 1,000 implants account for more than 250 patient years on the Total Artificial Heart


2012 ::  2011 :: 2010 :: 2009 :: 2008 :: 2007 :: 2006 :: 2005 :: 2004

SynCardia Posts Record Revenue and Profit in Q1 2012

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced record-setting revenue for the quarter ended March 31, 2012, due in part to Certified Centers performing a record number of implants of the SynCardia temporary Total Artificial Heart... read more

Cedars-Sinai Implants 1st SynCardia Total Artificial Heart
to Bridge Mother of Three to Second Heart Transplant

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, said today that Cedars-Sinai Medical Center in Los Angeles has discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart. Michelle Johnson, 39, left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power her Total Artificial Heart... read more

8 SynCardia Certified Centers & Surgeons Honored
for Use of Total Artificial Heart at ISHLT

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, honored eight SynCardia Certified Centers and surgeons for their use of the SynCardia temporary Total Artificial Heart and the Freedom® portable driver during the annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) held April 18-21 in Prague, Czech Republic... read more

Retired Pro Hockey Player 1st to Receive Total Artificial Heart
in Upstate New York

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that retired professional hockey player and two-time Olympian, Gaetano "Gates" Orlando, has become the first person in upstate New York to receive the SynCardia temporary Total Artificial Heart. The 49-year-old, who played for the Buffalo Sabres and Rochester Americans, as well as the Italian national team in the 1994 and 1998 Olympics, received the Total Artificial Heart on April 4, at University of Rochester Medical Center (URMC)... read more

SynCardia's Total Artificial Heart Receives HUD Designation
for Destination Therapy from FDA

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration (FDA) has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant... read more

Record Number of ISHLT Abstracts Discuss SynCardia's Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that this year's annual meeting of the International Society for Heart & Lung Transplantation (ISHLT) being held April 18-21 in Prague, Czech Republic, features a record number of abstracts discussing the SynCardia temporary Total Artificial Heart... read more

University of Washington Medical Center 1st in Pacific Northwest
to Discharge a Patient Without a Human Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that on March 21, University of Washington (UW) Medical Center became the first hospital in the Pacific Northwest to discharge a patient without a human heart. Christopher Marshall, 51, is now waiting for a matching donor heart in Seattle using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart... read more

University of Kentucky Medical Center Discharges
State's 1st SynCardia Total Artificial Heart Patient

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that on March 5, University of Kentucky Medical Center (UK) in Lexington discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart. Zack Poe, 20, is the first patient in the state to leave the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart... read more

1st Total Artificial Heart Patient Discharged Home
from Sentara Heart Hospital

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on March 7, Sentara Heart Hospital in Norfolk, VA, discharged its first Total Artificial Heart patient home using the Freedom® portable driver... read more

*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.